Medical characteristics of subjects with newly initiated use of calcium channel blockers, beta-receptor blockers, angiotensin converting enzyme inhibitors and angiotensin ii receptor blockers in subjects hospitalized due to hyponatremia (cases) versus subjects with newly initiated use with the same drugs but not hospitalized due to hyponatremia (controls). This evidence concerns the gene ACE and Hyponatremia.